e-learning
resources
ERJ
2004
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung fibroblasts from patients with emphysema show a reduced proliferation rate in culture
Holz O., Zuhlke I., Jaksztat E., Muller K.C., Welker L., Nakashima M., Diemel K.D., Branscheid D., Magnussen H., Jorres R.A.
Source:
Eur Respir J 2004; 24 : 575-579
Journal Issue:
October
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Holz O., Zuhlke I., Jaksztat E., Muller K.C., Welker L., Nakashima M., Diemel K.D., Branscheid D., Magnussen H., Jorres R.A.. Lung fibroblasts from patients with emphysema show a reduced proliferation rate in culture. Eur Respir J 2004; 24 : 575-579
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Primary human airway epithelial cells inhibit proliferation of lung fibroblasts
via
transforming growth factor-β
Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight
Year: 2007
Cigarette smoke inhibits lung fibroblast proliferation by translational mechanisms
Source: Eur Respir J 2012; 39: 705-711
Year: 2012
Mesenchymal stem cells isolated from fibrotic human lung tissue inhibit collagen expression by lung fibroblasts
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
The secretome of induced pluripotent stem cells (iPSC) modulates macrophage phenotype in the fibrotic lung
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Altered phenotype of COPD primary fibroblasts from airway and alveolar tissues: proliferation and apoptosis.
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019
Fibroblast growth factor 9 (FGF9) modulates mesothelial cells plasticity to decrease differentiation and migration in vitro
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
Lung fibroblasts from COPD patients presented a reduced response to TGF-β1 for proliferation and elastin synthesis
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011
Fibroblast growth factor 9 (FGF9) modulates the phenotype of control and fibrotic human lung fibroblasts
in vitro
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
LSC Abstract – Activation of FGF9 and 18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
Differences of
in vitro
proliferation between skin and lung parenchymal fibroblasts in patients with emphysema
Source: Eur Respir J 2006; 28: Suppl. 50, 796s
Year: 2006
Telomerase activity in bleomycin-induced epithelial cell apoptosis and lung fibrosis
Source: Eur Respir J 2007; 30: 205-213
Year: 2007
Apoptotic cell instillation after bleomycin attenuates lung injury through hepatocyte growth factor induction
Source: Eur Respir J 2012; 40: 424-435
Year: 2012
Primary airway epithelial cell culture from lung transplant recipients
Source: Eur Respir J 2005; 26: 1080-1085
Year: 2005
Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells
Source: Eur Respir J 2012; 39: 446-457
Year: 2012
KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts
Source: Eur Respir J 2006; 28: Suppl. 50, 340s
Year: 2006
Targetingpyruvate kinase M2 isoform inhibits proliferation of human lung fibroblasts
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
The effects of hypoxia on the expression of MMP-2, MMP-9 in human lung adenocarcinoma A549 cells
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014
The enhancement of Stanniocalcin-1 (STC1) secretion increases the ability of mesenchymal stem cells (MSCs) to reduce bleomycin-induced lung fibrosis in a mouse model through inhibition of endoplasmic reticulum stress (ER-stress)/TGFbeta1 pathway
Source: International Congress 2014 – ILDs 1
Year: 2014
Human lung mast cells alter asthmatic airway epithelial cell function
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept